Spectrum Pharmaceuticals, Inc. (SPPI) Easily Tops Q3 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q3 EPS of $0.34, $0.24 better than the analyst estimate of $0.10. Revenue for the quarter came in at $51.02 million versus the consensus estimate of $40.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Sound Finl Bancorp (SFBC) Tops Q3 EPS by 90c
- Christopher & Banks (CBK) Tops Q3 EPS by 79c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
